Short Interest in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Rises By 7.5%

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,990,000 shares, an increase of 7.5% from the October 15th total of 5,570,000 shares. Based on an average trading volume of 1,480,000 shares, the short-interest ratio is presently 4.0 days.

Wall Street Analysts Forecast Growth

ACHC has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Barclays lowered their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, September 30th. StockNews.com raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, November 14th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Finally, KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, Acadia Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $83.33.

Acadia Healthcare Price Performance

Shares of ACHC opened at $37.13 on Tuesday. The stock has a market cap of $3.45 billion, a PE ratio of 12.17, a price-to-earnings-growth ratio of 1.68 and a beta of 1.33. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The firm’s 50-day simple moving average is $57.27 and its two-hundred day simple moving average is $65.34.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.91 earnings per share. Analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. Blue Trust Inc. grew its holdings in Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares during the period. GAMMA Investing LLC grew its holdings in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Acadia Healthcare during the second quarter valued at approximately $59,000. Covestor Ltd grew its holdings in shares of Acadia Healthcare by 834.4% during the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after buying an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Acadia Healthcare during the third quarter valued at approximately $86,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.